Open Access Policy
American Journal Of Biomedical Science & Pharmaceutical Innovation (AJBSPI)
The American Journal Of Biomedical Science & Pharmaceutical Innovation (AJBSPI) is committed to the principle that scientific knowledge should be freely accessible to researchers, healthcare professionals, educators, policymakers, students, and the general public worldwide. The journal operates under a full Open Access publishing model, ensuring that all published articles are available online without subscription fees or access restrictions.
Our Open Access Commitment
AJBSPI believes that unrestricted access to scholarly research promotes the advancement of biomedical sciences, pharmaceutical innovation, healthcare research, and global scientific collaboration.
All articles published in the journal are made freely available immediately upon publication, allowing readers to access, read, download, distribute, and cite research without financial or technical barriers.
Benefits of Open Access
Open Access publishing provides numerous benefits to authors and readers, including:
- Increased visibility and discoverability of research
- Greater citation potential and academic impact
- Immediate worldwide access to published articles
- Enhanced knowledge sharing across institutions and countries
- Faster dissemination of scientific findings
- Support for innovation and evidence-based practice
- Improved collaboration among researchers and healthcare professionals
Access Rights
All published content is freely available to users without the need for:
- Subscription Fees
- Registration Charges
- Pay-Per-View Access
- Institutional Access Requirements
Readers may:
- Read articles online
- Download full-text articles
- Print articles for personal and academic use
- Share articles with colleagues and students
- Reference and cite published work in accordance with scholarly standards
Author Rights
Authors retain the intellectual responsibility for their published work and receive full acknowledgment and attribution for their contributions.
Authors benefit from:
- Global exposure of their research
- Immediate accessibility of their published articles
- Long-term preservation of scholarly work
- Increased opportunities for academic recognition and citation
Permanent Accessibility
AJBSPI is committed to ensuring the long-term availability and preservation of published content through digital archiving and online accessibility mechanisms.
Published articles remain permanently accessible to the global research community, supporting the continuous dissemination of scientific knowledge.
Quality and Peer Review
Open Access does not compromise scholarly quality.
All manuscripts submitted to AJBSPI undergo:
- Initial Editorial Screening
- Plagiarism Assessment
- Double-Blind Peer Review
- Editorial Evaluation
- Final Publication Decision
Publication decisions are based solely on scientific merit, originality, relevance, and reviewer recommendations.
Commitment to Knowledge Dissemination
The American Journal Of Biomedical Science & Pharmaceutical Innovation supports the global movement toward open science and unrestricted access to scholarly knowledge. By removing barriers to information, the journal seeks to promote scientific progress, encourage innovation, and enhance the impact of biomedical and pharmaceutical research worldwide.